P Vague

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

P Vague, I. Juhan‐Vague, Marie Françoise Aillaud et al. · Metabolism · 1986 · 448 citations

Obesity, Metabolic Syndrome, Metabolic Disorder +10

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

M Apfelbaum, P Vague, Olivier Ziegler et al. · The American Journal of Medicine · 1999 · 348 citations

Obesity, Metabolic Syndrome, Nutrition +13

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart

P Vague, Jean-Louis Sélam, Svein Skeie et al. · Diabetes Care · 2003 · 293 citations · Full text

Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma Insulin

I. Juhan‐Vague, C. Roul, Marie‐Christine Alessi et al. · Thrombosis and Haemostasis · 1989 · 291 citations

Hyperlipidemia, Pharmacotherapy, Insulin Signaling +19

The Effect of Metformin on the Metabolic Abnormalities Associated With Upper-Body Fat Distribution. BIGPRO Study Group

Annick Fontbonne, Marie‐Aline Charles, I. Juhan‐Vague et al. · Diabetes Care · 1996 · 284 citations